Executive Summary
55 fgf-23 is a peptide hormone secreted by FGF23 is a 251 amino-acid protein by RE Afsar·2023·Cited by 24—Fibroblast growth factor 23 (FGF23) is an endocrine hormone secreted from boneand has systemic actions on skeletal muscle. In CKD, FGF23 is elevated and
Fibroblast growth factor 23 (FGF23) is a crucial peptide hormone that plays a significant role in regulating mineral metabolism, particularly phosphate and vitamin D levels within the body. Primarily, FGF23 is a peptide hormone secreted by bone, with specialized bone cells known as osteoblasts and osteocytes being its main producers. However, emerging research indicates that the origins of this hormone may be more diverse than previously understood, with human skin cells express and secrete FGF23 as well.
The FGF23 gene provides the genetic instructions for creating this important protein. This Fibroblast growth factor 23 (FGF23) is a 251 amino-acid protein belonging to the broader fibroblast growth factor family. Its discovery has shed light on the intricate mechanisms governing phosphate and vitamin D homeostasis.
The Primary Role of FGF23 in Mineral Metabolism
The principal function of FGF-23 revolves around maintaining the delicate balance of phosphate and vitamin D in the bloodstream. When FGF23 is secreted by osteoblasts and osteocytes in bone, it travels to the kidneys, which are a key target organ. In the kidney's proximal tubules, FGF23 acts to reduce the reabsorption of phosphate, thereby increasing its excretion in urine. This phosphaturic effect is critical in preventing the buildup of excessive phosphate levels.
Furthermore, FGF23 significantly influences vitamin D metabolism. It suppresses the activity of the enzyme 1-alpha-hydroxylase in the kidneys, which is responsible for converting calcidiol to the active form of vitamin D, calcitriol (1,25-dihydroxyvitamin D). This action effectively reduces the production of active vitamin D, thereby lowering FGF23 effect on calcium absorption and contributing to overall mineral balance. This intricate interplay highlights the vital connection between FGF23 and vitamin D metabolism.
Factors Influencing FGF23 Secretion
The secretion of FGF23 is not a constant process but is rather influenced by several physiological factors. Vitamin D sterols increase FGF23 expression by stimulating its production. Additionally, levels of phosphate and parathyroid hormone (PTH) also play a role. When phosphate concentrations are high, or in response to certain forms of PTH, FGF23 secretion is stimulated. Conversely, FGF23 is a negative regulator of PTH mRNA expression and secretion, indicating a feedback loop that helps maintain hormonal equilibrium.
FGF23 Beyond Bone: Emerging Insights
While bone remains the primary site where FGF23 is produced, recent studies have expanded our understanding of its distribution and potential functions. As mentioned, human skin cells express and secrete FGF23, suggesting that the skin might also contribute to circulating levels of this hormone. This finding opens new avenues for research into the diverse roles of FGF23.
Moreover, FGF23 has been implicated in various physiological processes beyond mineral metabolism. Its systemic actions extend to skeletal muscle, and in conditions like chronic kidney disease (CKD), FGF23 is elevated. Research is ongoing to explore the full spectrum of FGF23 disease associations and its role in conditions such as muscle wasting. The relationship between FGF23 and Klotho, a peptide that affects the parathyroid gland and kidney via FGF23, is also an active area of investigation, particularly concerning its potential impact on insulin resistance.
Clinical Significance and Testing
Understanding the levels of FGF23 in the body can be clinically significant. A Fibroblast growth factor 23 blood test can help assess conditions related to mineral imbalances and bone health. Abnormalities in FGF23 levels can be indicative of various disorders, including FGF23 deficiency or conditions where its production is dysregulated. The precise measurement of this peptide is therefore crucial for accurate diagnosis and patient management.
In summary, Fibroblast growth factor 23 (FGF23) is a vital peptide hormone secreted by bone, primarily by osteoblasts and osteocytes. Its main role is to regulate phosphate and vitamin D levels, acting mainly on the kidneys. However, the discovery that human skin cells express and secrete FGF23 hints at a broader physiological significance. Continued research into this complex hormone promises to unlock further insights into its multifaceted roles in health and disease.
Related Articles
Frequently Asked Questions
Here are the most common questions about 55 fgf-23 is a peptide hormone secreted by.
Leave a Comment
Share your thoughts, feedback, or additional insights on this topic.
